• Post Market Surveillance

    By strengthening post-market surveillance we establish an effective monitoring system.

  • Industry Regulation

    We ensure that all drugs and related products comply with and adhere to statutory requirements

  • Compliance with Standards

    Drugs and other products are regularly tested for compliance. This photograph shows a condom testing machine.

  • Testing and Research

    Scientists in the microbiology lab testing samples

  • Report Adverse Drug Reactions

    Adverse Drug Reactions

    Always report adverse drug reactions. Click here to report

Welcome to Our Website

The Pharmacy Board of Sierra Leone is the medicines regulatory agency in the country and was set up by an Act of Parliament in 1988 with the mission of ensuring that appropriate and workable regulatory guidelines are implemented in order to achieve the highest practicable standards of the practice of pharmacy by professionals and of safety, efficacy and quality of all drugs, medical devices, cosmetics and nutritional agents (collectively termed ‘products) locally manufactured, imported, exported, distributed, sold or used to ensure the protection of the public health as envisaged by the Pharmacy and Drugs Act...Read More

PUBLIC NOTICE: RENEWAL OF ANNUAL LICENSES

 Date of issue of Public Notice:  1st July, 2019

 THE PHARMACY BOARD OF SIERRA LEONE (PBSL) WOULD LIKE TO INFORM THE GENERAL PUBLIC AND ALL PERSONS ENGAGED IN PHARMACY BUSINESS (I.E. PHARMACY STORES, DRUG STORES, PATENT MEDICINE SHOPS) AND ALSO THOSE ENGAGED IN THE SELLING OF COSMETIC PRODUCTS, NUTRITIONAL AGENTS AND ENERGY DRINKS THAT THE DEADLINE DATE FOR THE RENEWAL OF THEIR ANNUAL LICENSES FOR THE YEAR 2019 IS ON THE 31ST JULY, 2019.

 IN THIS REGARD, THE PHARMACY BOARD OF SIERRA LEONE HERBY INFORMS THE GENERAL PUBLIC THAT ALL PERSONS CONCERNED ARE REQUIRED TO TAKE IMMEDIATE STEPS TO OBTAIN THEIR APPROPRIATE LICENSES [IN ACCORDANCE WITH PART IV SECTIONS 17, 18, 19 AND 20, SUBSECTIONS (1) AND (2) OF THE PHARMACY AND DRUGS ACT, 2001  FROM THE PHARMACY BOARD IN ACCORDANCE WITH PART IV SECTIONS 17, 18, 19 AND SECTION 20 SUBSECTIONS (1) AND (2) OF THE PHARMACY AND DRUGS ACT, 2001] FROM THE OFFICE OF THE PHARMACY BOARD SITUATED AT THE CENTRAL MEDICAL STORES COMPOUND, NEW ENGLAND VILLE, FREETOWN OR FROM THE REGIONAL PHARMACY BOARD OFFICES IN BO, KENEMA, MAKENI, KONO AND LUNGI.

THE GENERAL PUBLIC IS HEREBY INFORMED THAT CLOSURES OF ALL UNLICENSED PREMISES WILL COMMENCE ON THURSDAY 1ST OF AUGUST, 2019.

YOUR COOPERATION IN THIS ALL IMPORTANT MATTER OF PUBLIC HEALTH AND NATIONAL DEVELOPMENT IS SOLICITED.

SIGNED

JAMES P. KOMEH   

Description: F:\Registrar Signature.jpg


 

 

                                          

Public Notice: Drug Alert

Please be informed that it has been brought to the attention of the Pharmacy Board of Sierra Leone that the under mentioned product is a counterfeit, illegally imported and is not registered by the Pharmacy Board of Sierra Leone contrary to Part VI Section (44) and (55) of the Pharmacy and Drugs Act 2001.  

The Pharmacy Board of Sierra Leone therefore cannot guarantee the quality and safety of this product and therefore warns the General Public against its distribution and use.

NOVALGIN I.V. & I.M                                     Manufacturing date: 06/2018

Strength: 500mg/5ml                                    Expiry date: 06/2021

Batch Number: 180616                                Manufactured by: Shanghai Medsys Industrial Co.Ltd

All concerned are kindly requested to forward all batches of this product to the Pharmacy Board of Sierra Leone Head Quarter at Central Medical Stores, New England Ville, Freetown or to any of its regional offices in Bo, Kenema, Makeni and Kono for further regulatory action.

Signed:

James P. Komeh

Registrar

Public Notice: Drug Alert

Information making rounds on social media about a certain drug called “Menthodex” (pictured below) with an incorrect manufacturing date has been brought to the attention of the pharmacy board. From our investigations, our findings indicate that regulators intercepted the drug in Nigeria and due to our bilateral ties with National Agency for Food and Drug Administration and Control (NAFDAC) Nigeria the Board was notified to be extra vigilant for the product in our market. The board has intensified its post-market surveillance and we will continue to keep the general public updated.

The general public is hereby advised to carefully check the manufacturing details of drugs they purchase and should be rest assured that products registered by Pharmacy Board of Sierra Leone are of good quality, efficacious and safe.

            February, 2019

 

 

29

Jan

Press Release

Important announcement concerning a brand of amoxycillin capsules that allegedly caused two deaths, according to an audio clip in circulation. The Board is unaware of and has never registered such a brand of amoxycillin. Read More

31

Jan

Drug Alert: Chloroquine

With immediate effect, Chloroquine phosphate injection manufactured by Syncom Formulations Ltd, India, is to be withdrawn from circulation and quarantined. Read More